Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Determination of the in vivo significance of LDL receptor-related protein 1 (LRP1) dysfunction on lipid metabolism and atherosclerosis development in absence of its main ligand apoE. METHODS AND RESULTS: LRP1 knock-in mice carrying an inactivating mutation in the NPxYxxL motif were crossed with apoE-deficient mice. In the absence of apoE, relative to LRP1 wild-type animals, LRP1 mutated mice showed an increased clearance of postprandial lipids despite a compromised LRP1 endocytosis rate and inefficient insulin-mediated translocation of the receptor to the plasma membrane, likely due to inefficient slow recycling of the mutated receptor. Postprandial lipoprotein improvement was explained by increased hepatic clearance of triglyceride-rich remnant lipoproteins and accompanied by a compensatory 1.6-fold upregulation of LDLR expression in hepatocytes. One year-old apoE-deficient mice having the dysfunctional LRP1 revealed a 3-fold decrease in spontaneous atherosclerosis development and a 2-fold reduction in LDL-cholesterol levels. CONCLUSION: These findings demonstrate that the NPxYxxL motif in LRP1 is important for insulin-mediated translocation and slow perinuclear endosomal recycling. These LRP1 impairments correlated with reduced atherogenesis and cholesterol levels in apoE-deficient mice, likely via compensatory LDLR upregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Self-citationTabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944 · cited 1×
“Homozygous LRP1 knock-in mutant mice (mixed C57Bl/6J and 129 background), containing the previously described NPxYxxL knock-in mutation (PTNFTNPVYATL PTNFTAAVAATL, LRP1) [22], were crossed with homozygous apoE knock-out mice (apoE) [23] on a C57BL/6J background (Jackson Laboratories, Bar Harbor, Maine, USA).”
BackgroundMahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455 · cited 3×
“Currently it is believed that hepatic LRP1 serves as a back-up receptor for LDLR in mediating TRL clearance as its absence in the liver in mice only affects triglyceride levels in LDLR deficiency [6].”
BackgroundInfluentialMahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447
Schneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110330 · Cited by 310 · cited 1×
“The primary molecular cause for type III hyperlipidemia is APOE2 homozygosity as it is characterized by a very low binding affinity to the LDLR [3,13].”
BackgroundStanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226 · cited 1×
“One of its functions is to serve as a ligand that mediates the binding, uptake, and plasma clearance of TRLs via cell surface receptors being the heparan sulfate proteoglycan (HSPG) syndecan 1, the LDL Receptor (LDLR), and LDLR-Related Protein 1 (LRP1) [4–9].”
BackgroundMacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., & Esko, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29154 · Cited by 216 · cited 1×
“One of its functions is to serve as a ligand that mediates the binding, uptake, and plasma clearance of TRLs via cell surface receptors being the heparan sulfate proteoglycan (HSPG) syndecan 1, the LDL Receptor (LDLR), and LDLR-Related Protein 1 (LRP1) [4–9].”
BackgroundMacrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation
Yancey, P. G., Blakemore, J., Ding, L., Fan, D., Overton, C. D., Zhang, Y., Linton, M. F., & Fazio, S. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202051 · Cited by 168
Mahley, R. W., & Huang, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30889 · Cited by 159 · cited 2×
“The clearance of postprandial triglyceriderich remnants at the liver in the space of Disse is mediated via three receptor systems being syndecan 1, LRP1, and LDLR [37].”
BackgroundResultSignaling through LRP1: Protection from atherosclerosis and beyond
Boucher, P., & Herz, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.09.018 · Cited by 122 · cited 3×
“Studies published thus far have demonstrated that LRP1 inactivation is correlated with deleterious effects on atherosclerosis [7,18,20,21].”
BackgroundResultYancey, P. G., Ding, Y., Fan, D., Blakemore, J. L., Zhang, Y., Ding, L., Zhang, J., Linton, M. F., & Fazio, S. (2011) · Circulation · doi:10.1161/circulationaha.111.032268 · Cited by 83
Donoso, M., Cancino, J., Lee, J., van Kerkhof, P., Retamal, C., Bu, G., Gonzalez, A., Cáceres, A., & Marzolo, M.-P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0805 · Cited by 69
LRP1 Controls cPLA2 Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export
Zhou, L., Choi, H. Y., Li, W.-P., Xu, F., & Herz, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006853 · Cited by 45 · cited 2×
“The impact of LRP1 dysfunction on cardiovascular disease likely extends beyond effects on the lipoprotein metabolism, as apoE mediates its inhibitory signals on SMC migration in part via LRP1 [17] and because other signaling pathways involved in atherosclerosis, like Liver X Receptor-mediated gene transcription, are a…”
Background
Cited by
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Gordts, P. L. S. M., Nock, R., Son, N.-H., Ramms, B., Lew, I., Gonzales, J. C., Thacker, B. E., Basu, D., Lee, R. G., Mullick, A. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86610 · Cited by 274
Self-citationRecent advances in physiological lipoprotein metabolism
Ramasamy, I. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0358 · Cited by 235
“Studies in mice suggest that in an apoE deficient model, in which LRP1 (the largest member of the low density lipoprotein receptor family) mediated clearance of lipoprotein particles is impaired, further LRP1 dysfunction drives the system to compensate by upregulation of LDR receptor expression [94].”
BackgroundVan Gool, B., Storck, S. E., Reekmans, S. M., Lechat, B., Gordts, P. L. S. M., Pradier, L., Pietrzik, C. U., & Roebroek, A. J. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1594-2 · Cited by 114
Self-citationApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
“In general, the WD increased cholesterol levels, as expected, and decreased TG levels, as observed in previous studies using Apoe / mice (30).”
Self-citationLRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype
Maier, W., Bednorz, M., Meister, S., Roebroek, A., Weggen, S., Schmitt, U., & Pietrzik, C. U. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-25 · Cited by 50
“Generation of cells from mice carrying a knock-in mutation in the NPxYxxL (NPxY2) sequence revealed a reduced internalization rate for LRP1 [2-4].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Gordts, P. L. S. M., Bartelt, A., Nilsson, S. K., Annaert, W., Christoffersen, C., Nielsen, L. B., Heeren, J., & Roebroek, A. J. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-06
- Volume
- 7
- Issue
- 6
- Pages
- e38330
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2145204479
- Cited by
- 32
- References
- 15
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.